KATO III/iRFP stable cell line

KATO III/iRFP cells are derived from human gastric cancer cell line KATO III by stably integration of a constitutive miRFP670 stably expression construct. KATO III cells are valuable for studying gastric cancer biology, including the mechanisms of tumor growth, metastasis, and response to therapies. KATO III/iRFP cells stably express miRFP670, can be used for in vitro assays and in vivo imaging.